| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2025 | 17 May 2025 |
| Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve 1. Approval of the Audited Financial Results of the Company for the quarter and Yearly ended 31st March 2025; 2. Any other business with the permission of Chairperson. Outcome of Board Meeting for Approval of Audited Financials for the year ended 31st March,2025 (As Per BSE Announcement Dated on :26.05.2025) Audited Financial Results for the year ended 31st March ,2025 (As Per BSE Announcement Dated on :26.05.2025) | ||
| Board Meeting | 21 Jan 2025 | 13 Jan 2025 |
| BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 inter alia to consider and approve 1) the Un-Audited Financial Results along with Limited Review Report of the Company for the Quarter ended 31st December 2024. 2) Other routine business with the permission of the Chair. Outcome of Board meeting (As Per BSE Announcement Dated on: 21/01/2025) | ||
| Board Meeting | 12 Nov 2024 | 12 Nov 2024 |
| Submission of Corrigendum to the Notice of EOGM dated 15/10/2024 submitted on 23/10/2024 as per attachment | ||
| Board Meeting | 23 Oct 2024 | 16 Oct 2024 |
| BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September 2024. 2) Other routine business with the permission of the Chair. outcome of Board Meeting held on 23rd October 2024 (As Per BSE Announcement Dated on: 23/10/2024) | ||
| Board Meeting | 15 Oct 2024 | 10 Oct 2024 |
| BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2024 inter alia to consider and approve items mentioned in the notice of Board meeting. Outcome of Board Meeting held on 15th October,2024 Approved the acquisition of 5527000 Equity shares of M/s. CNX Corporation Limited (CCL) subject to approval of members of the Company at ensuing Extra Ordinary General Meeting. Revised Outcome of Board Meeting due to clerical mistake in list of allotee. (As Per BSE Announcement dated on 15.10.2024) | ||
| Board Meeting | 27 Sep 2024 | 21 Sep 2024 |
| BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/09/2024 inter alia to consider and approve matters stated in intimation OUTCOME OF BOARD MEETING HELD ON 27TH SEPTEMBER, 2024. (As per BSE Announcement Dated on 27/09/2024) | ||
| Board Meeting | 2 Sep 2024 | 2 Sep 2024 |
| Approval Of Notice Of Annual General Meeting And Board Of Directors Report, Fixation Of Book Closure For AGM And Remote Evoting Facility, Appointment Of Scrutinizer Along With Routine Business. | ||
| Board Meeting | 31 Aug 2024 | 31 Aug 2024 |
| outcome of Board Meeting held on 31.08.2024 | ||
| Board Meeting | 28 Aug 2024 | 28 Aug 2024 |
| 1. Considered & Approved Appointment of Ms. Avani Savjibhai Godhaniya (DIN: 10387729) as an Additional Director in the category of Non-Executive - Independent Director in the Company, not liable to retire by rotation, on the Board of Directors of the Company with effect from 28th August, 2024 for a first term of 5 (five) Years, i.e upto 27th August,2029 subject to members approval at its General Meeting. 2. Considered & Approved Appointment of Mr. Dinesh Chander Notiyal (DIN: 10289995) as an Additional Director in the category of Non-Executive - Independent Director in the Company , not liable to retire by rotation, on the Board of Directors of the Company with effect from 28th August,2024 for a first term of 5 (five) Years, i.e upto 27th August,2029 subject to members approval at its General Meeting. | ||
| Board Meeting | 14 Aug 2024 | 7 Aug 2024 |
| BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. the Un-Audited Financial Results along with Limited Review Report for the Quarter ended 30th June 2024. 2. Any other item with permission of the Chair. Outcome of Board Meeting held on 14th August 2024 (As Per Bse Announcement Dated on 14.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.